Form 4 for IDXX Idexx Laboratories
Accepted 2024-05-08 00:00:00 ET · period of report 2024-05-06 · accession 0000874716-24-000104 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DI | 2024-05-08 | 2024-05-08 | IDXX | SZOSTAK M ANNE | Dir | G - Gift | $0.00 | +257 | 6,561 | +4% | $0 |
| D | 2024-05-08 | 2024-05-06 | IDXX | SZOSTAK M ANNE | Dir | M - OptEx | $0.00 | +257 | 257 | New | $0 |
| D | 2024-05-08 | 2024-05-08 | IDXX | SZOSTAK M ANNE | Dir | G - Gift | $0.00 | -257 | 0 | -100% | $0 |
| DM | 2024-05-08 | 2024-05-06 | IDXX | SZOSTAK M ANNE | Dir | A - Grant | $0.00 | +871 | 609 | New | $0 |
| D | 2024-05-08 | 2024-05-06 | IDXX | SZOSTAK M ANNE | Dir | M - OptEx | $0.00 | -257 | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-05-08 | G | A | 257 | $0.00 | 6,561 | I | — | — | (F1) Includes 1,604 shares of IDEXX Laboratories, Inc. common stock contributed by the reporting person to the Trust of M. Anne Szostak (as defined in note (2) below). |
| 2 | Common | Common Stock | 2024-05-06 | M | A | 257 | $0.00 | 257 | D Trust of M. Anne Szostak | — | — | (F2) The reporting person is the settlor of the Trust of M. Anne Szostak ('Trust') and the trustee of the Trust, has power to direct the distribution of Trust assets, and has the power to revoke or amend the Trust. The reporting person has a pecuniary interest in the shares transferred to the Trust. |
| 3 | Common | Common Stock | 2024-05-08 | G | D | 257 | $0.00 | 0 | D | — | — | |
| 4 | Derivative | Restricted Stock Unit | 2024-05-06 | A | A | 262 | $0.00 | 262 | D | — · — to — | 262 Common Stock | (F4) Each restricted stock unit represents a contingent right to receive one share of IDEXX Laboratories, Inc. common stock. These restricted stock units vested in in one installment on the one year anniversary of the date of grant or on the date of the 2025 annual meeting of shareholders, whichever event is earlier. |
| 5 | Derivative | Non-Qualified Stock Option (right-to-buy) | 2024-05-06 | A | A | 609 | $0.00 | 609 | D | $476.87 · — to 2034-05-05 | 609 Common Stock | (F3) Grant of option to buy shares of IDEXX Laboratories, Inc. common stock that vest in one installment on the one year anniversary of the date of grant or on the date of the 2025 annual meeting of shareholders, whichever event is earlier. |
| 6 | Derivative | Restricted Stock Unit | 2024-05-06 | M | D | 257 | $0.00 | 0 | D | — · — to — | 257 Common Stock | (F5) Each restricted stock unit represents a contingent right to receive one share of IDEXX Laboratories, Inc. common stock. Restricted stock units vest in in one installment on the one year anniversary of the date of grant or on the date of the 2024 annual meeting of shareholders, whichever event was earlier. |